Catalyst Fund I had a stated objective of investing in some of the most promising early stage companies in the AngelMD community. While AngelMD serves as a General Partner (GP) of the fund, the fund is managed by an independent Managing Partner.

With the post investment resources of the AngelMD community at their disposal, Catalyst Fund portfolio companies have an edge in their maturation process. The fund invested in a dozen early stage companies split between medical device and therapeutics and the portfolio of companies continues to perform exceptionally well. The fund is fully allocated. Future funds may be introduced, but for the time being, AngelMD Capital LLC is focused on its Managed Syndicate offering.